ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,861Medicare Part D Prescriptions Filled, Including Refills

Rank: 94 out of 680

$1.39M Total Retail Price of All Prescriptions

Rank: 30 out of 680

323 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 323 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 13,700 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

43% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$88 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

49 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
OMEPRAZOLE 531 485 1 7
POTASSIUM CHLORIDE 496 439 2 14
ATORVASTATIN CALCIUM 478 433 3 11
NEXIUM 467 404 4 16
FUROSEMIDE 465 409 5 6
CRESTOR 445 364 6 25
AMLODIPINE BESYLATE 421 373 7 1
METOPROLOL SUCCINATE 336 264 8 13
BYSTOLIC 291 250 9 79
CLOPIDOGREL 275 249 10 26
DIOVAN HCT 264 230 11 55
METFORMIN HCL 252 185 12 8
HYDROCHLOROTHIAZIDE 246 218 13 9
PLAVIX 221 203 14 39
LEVOTHYROXINE SODIUM 219 208 15 2
CYMBALTA 205 176 16 46
LIPITOR 202 175 17 68
SINGULAIR 202 185 17 91
TRAMADOL HCL 201 183 19 18
CLONIDINE HCL 199 156 20 36
DIOVAN 198 169 21 31
PRAVASTATIN SODIUM 180 171 22 10
SIMVASTATIN 168 146 23 3
TAMSULOSIN HCL 158 140 24 34
ALLOPURINOL 158 147 24 33
LYRICA 156 138 26 77
COREG CR 150 148 27 293
DOXAZOSIN MESYLATE 137 104 28 73
EXFORGE HCT 136 100 29 296
CARVEDILOL 129 128 30 23
HYDROCODONE-ACETAMINOPHEN 129 119 S3 30 4
DONEPEZIL HCL 124 124 32 27
NOVOLOG 123 123 33 167
WARFARIN SODIUM 119 116 34 20
MONTELUKAST SODIUM 118 109 35 157
ATENOLOL 117 109 36 19
JANUVIA 115 104 37 60
GLIPIZIDE 105 78 38 63
ADVAIR DISKUS 103 67 39 53
NAMENDA 99 99 40 35
AMITRIPTYLINE HCL 98 96 R 41 47
GABAPENTIN 97 64 42 15
LISINOPRIL 97 77 42 5
METOPROLOL TARTRATE 96 88 44 12
AZITHROMYCIN 95 83 45 42
NITROGLYCERIN PATCH 94 94 46 271
PREDNISONE 94 78 46 50
LOSARTAN POTASSIUM 93 72 48 21
ZOLPIDEM TARTRATE 93 71 48 17
DIGOXIN 92 83 50 58
BENICAR HCT 91 82 51 150
LOSARTAN-HYDROCHLOROTHIAZIDE 89 80 52 51
EVISTA 88 71 53 135
LANTUS 86 86 54 49
SPIRIVA 84 69 55 70
INSULIN SYRINGE 83 83 56 86
ALENDRONATE SODIUM 82 82 57 32
BISOPROLOL-HYDROCHLOROTHIAZIDE 80 70 58 156
ISOSORBIDE MONONITRATE ER 80 75 58 59
JANUMET 79 72 60 194
METOCLOPRAMIDE HCL 79 69 60 118
SPIRONOLACTONE 77 70 62 82
EXFORGE 74 61 63 151
CIPROFLOXACIN HCL 73 60 64 57
AMITIZA 71 58 65 270
AMOXICILLIN 69 48 66 111
DEXILANT 68 52 67 171
QUETIAPINE FUMARATE 68 58 67 64
AZOR 66 54 69 278
CYCLOBENZAPRINE HCL 64 46 R 70 81
PROCRIT 64 64 70 421
KLOR-CON M20 62 62 72 61
PANTOPRAZOLE SODIUM 62 41 72 30
MEGESTROL ACETATE 61 61 R 74 88
HYDRALAZINE HCL 61 51 74 71
SPS 60 60 76 340
RAMIPRIL 58 55 77 69
POLYETHYLENE GLYCOL 3350 56 53 78 62
TRIBENZOR 50 49 79 321
SEROQUEL 50 47 79 123
CEPHALEXIN 50 41 79 149
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.